Roles and Responsibilities of Nurses in Tobacco Control and Addiction Treatment

Year 2025, Volume: 26 Issue: 2, 235 - 246, 30.06.2025

Songül Kamışlı

https://doi.org/10.51982/bagimli.1537821

Abstract

Although tobacco addiction is one of the most preventable causes of disease and death, 8 million people worldwide lose their lives each year due to direct or indirect causes related to tobacco use. Combustible tobacco products like cigarettes and non-combustible products like hookah and e-cigarettes contain nicotine, which leads to addiction. Since tobacco addiction is both a physical and psychological dependence, pharmacological and psychosocial interventions are necessary for treatment. Most tobacco users attempt to quit but often fail. Treating tobacco addiction on its own is difficult, and therefore professional help is needed. Nurses, who are key members of the healthcare workforce, are essential health professionals who can assist with tobacco control and the treatment of tobacco addiction. Despite their known heavy workloads and long shifts, the smoking cessation counseling they provide can make significant contributions to the country's healthcare system, economy, and the quality of life in society. Nurses can contribute by providing counseling in addiction treatment, offering psychosocial support to individuals during their tobacco cessation efforts, and monitoring pharmacological treatments. Nurses who have received training in smoking cessation can enhance individuals' motivation to quit smoking, offer strategies to cope with addiction, and provide guidance. Additionally, by participating in tobacco control efforts, nurses can help raise public awareness and support efforts to reduce tobacco addiction. This article reviews the treatment and intervention efforts for tobacco addiction and discusses the counseling role of nurses.

Keywords

Tobacco prevention, smoking cessation, nursing, counselling

Project Number

-

Tütün Kontrolü ve Bağımlılığının Tedavisinde Hemşirelerin Görev ve Sorumlulukları

Abstract

Tütün bağımlılığı, önlenebilir en önemli hastalık ve ölüm nedenlerinden birisi olmasına rağmen dünyada 8 milyon insan tütün kullanımına bağlı doğrudan veya dolaylı nedenlerle yaşamını kaybetmeye devam etmektedir. Yanıcı tütün ürünü olan sigara ve yanıcı olmayan nargile, esigara ve diğer tüm tütün ürünlerinin kullanımı içerisinde bulunan nikotin nedeniyle bağımlılığa yol açmaktadır. Tütün bağımlılığı fiziksel ve psikolojik bir bağımlılık türü olması nedeniyle tedavisinde farmakolojik ve psikososyal müdahalelere ihtiyaç vardır. Çoğu tütün bağımlısı bırakmayı denemekte ancak başarısızlık yaşamaktadır. Tütün bağımlılığının tek başına tedavi edilmesi zordur ve bu nedenle profesyonel bir yardım gerekir. Sağlık hizmeti ordusunun önemli neferlerinden olan hemşireler tütün kontrolü ve tütün bağımlılığının tedavisinde rol ve görev alacak önemli sağlık personeli arasındadır. Yoğun iş yükü ve mesailerinin olduğu bilinmekle birlikte hemşirelerin yapacağı tütün tedavisi danışmanlığı ülkenin sağlık hizmetlerine, ekonomisine ve toplumun yaşam kalitesine ciddi katkılar sunacaktır. Hemşireler, bağımlılık tedavisinde danışmanlık yaparak ve tütün kullanımını bırakma sürecinde bireylere hem psikososyal destek sağlayarak hem de farmakolojik tedavileri takip ederek katkıda bulunabilirler. Sigara bıraktırma eğitimi almış hemşireler, bireylerin sigara bırakma sürecinde motivasyonlarını artırabilir, bağımlılık ile başa çıkma stratejileri sunabilir ve rehberlik yapabilir. Ayrıca, tütün kontrolü çalışmalarına katılarak toplumsal farkındalık oluşturma ve tütün bağımlılığını azaltma çabalarına destek olabilirler. Bu yazıda tütün bağımlılığının tedavisi ve müdahale çalışmaları gözden geçirilmiş, hemşirelerin danışmanlık rolü tartışılmıştır.

Keywords

Tütün kontrolü, sigara bırakma, hemşirelik, danışmanlık

Ethical Statement

Bu çalışma için ilgili Etik Kurul onayına gerek yoktur

Supporting Institution

Finansal bir destek alınmamıştır.

Project Number

-

Thanks

-

References

• WHO. WHO 2023, Tobacco. https://www.who.int/news-room/fact-sheets/detail/tobacco (Accessed 20.06.2024).
• Song, MA, Freudenheim JL, Brasky TM, et al. Biomarkers of exposure and effect in the lungs of smokers, nonsmokers, and electronic cigarette users, Cancer Epidemiol Biomark Prev 2020: 29(2): 443–451.
• Ergüder T. Tütün Kontrolü Çerçeve Sözleşmesı̇: Küresel Sağlık İçin, Küresel Eylem. Ankara: Klasmat Matbaacılık, 2008.
• T.C. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü. Küresel Gençlik Tütün Araştırması. Ankara: Artı6 Medya Tanıtım Matbaa, 2017.
• Tütün Kontrolü Strateji Belgesi ve Eylem Planı, 2018.https://havanikoru.saglik.gov.tr/depo/Dokumanlar/ulusal-tutun-kontrol-programi-eylem-plani.pdf (Accessed 25.06.2024).
• BEDAM, 2024, Tütün Kontrolü ve Sigara Bıraktırma Kursu, https://bedam.baskent.edu.tr/saglik-bakanligi-onayli-sertifika-programi-tutun-kontrolu-ve-sigara-birakma-kursu-basariyla-tamamlandi/(Accessed 25.10.2024).
• Prochaska JJ, Benowitz NL. Current advances in research in treatment and recovery: Nicotine addiction. Sci Adv 2019; 5(10): eaay9763.
• AHRQ 2012 Agency for Healthcare Research and Quality. Systems Change: Treating Tobacco Use and Dependence: Based on the Public Health Service (PHS) Clinical Practice Guideline-2008 Update. www.ahrq.gov/professionals/ clinicians-providers/guidelinesrecommendations/ tobacco/decisionmakers/syste ms/index. html December 2012 (Accessed 24.05.2024).
• Levine A, Huang Y, Drisaldi B et al. Molecular mechanism for a gateway drug: epigenetic changes initiated by nicotine prime gene expression by cocaine. Sci Transl Med 2011; 2(3): 107ra109.
• Ling PM, Glantz SA. Why and how the tobacco industry sells cigarettes to young adults: evidence from industry documents. Am J Public Health 2002; 92(6): 908–916.
• Buck JM, O’Neill HC, Stitzel JA. Developmental nicotine exposure engenders intergenerational downregulation and aberrant posttranslational modification of cardinal epigenetic factors in the frontal cortices, striata, and hippocampi of adolescent mice, Epigenet Chromatin 2020; 13(1): 13.
• Center for Behavioral Health Statistics and Quality. Impact of the DSM-IV to DSM-5 Changes on the National Survey on Drug Use and Health. Substance Abuse and Mental Health Services Administration, Rockville, MD. 2016.
• American Psychiatric Association (APA). Dıagnostic and Statistical Manual of Mental Disorders Fıfth Edition DSM-5. Washington: American Psychiatric Association, 2013..
• Benowitz NL, Hukkanen J, Jacob P. 3rd. Nicotine chemistry, metabolism, kinetics and biomarkers. Handb Exp Pharmacol 2009; 192: 29–60.
• Li X, Semenova S, D’Souza MS, et al. Involvement of glutamatergic and GABAergic systems in nicotine dependence: Implications for novel pharmacotherapies for smoking cessation. Neuropharmacology 2014; 76: 554–565.
• George O, Ghozland S, Azar MR, et al. CRF-CRF1 system activation mediates withdrawal-induced increases in nicotine self-administration in nicotine-dependent rats. Proc Natl Acad Sci USA 2007; 104(43): 17198–17203.
• Ruffin L, Padden-Denmead M, Lewis JB Jr, et al. A Comparison of Haitian and American bachelor of science in nursing students' perceptions of cigarette smoking and e-cigarette use. J Addict Nurs 2022; 33(2): 95-102.
• Heinly A, Walley S. The nicotine and tobacco epidemic among adolescents: new products are addicting our youth. Curr Opin Pediatr 2023; 35(4): 513-521.
• Huey SW, Granitto MH. Smoke screen: The teen vaping epidemic uncovers a new concerning addiction. J Am Assoc Nurse Pract. 2020; 32(4): 293-298.
• SB, 2024, 4207 Sayılı Tütün Ürünlerinin Zararlarının Önlenmesi ve Kontrolü Hakkında Kanun. https://www.saglik.gov.tr/TR,11141/4207-sayili-tutun-urunlerinin-zararlarinin-onlenmesi-ve-kontrolu-hakkinda-kanunun-uygulanmasi-ile-ilgili-200944-sayili-bakanligimiz-genelgesi.html. (Accessed 28.10.2024).
• Kamışlı S, Yüce D, Küçükçoban Ş, et al. Bir sigara bırakma polikliniğinde uygulanan psikoeğitimsel sigara bırakma programının etkinliği. Anadolu Hemşirelik ve Sağlık Bilimleri Dergisi. 2017; 20(4): 235-243.
• Feigenbaum, JC. Pharmacological Aids to Promote Smoking Cessation. J Addict Nurs 2010; 21(2–3): 87–97.
• Lindson N, Chepkin SC, Ye W et al. Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation. Cochrane Database Syst 2019; (4): CD013308.
• Mills EJ, Thorlund K, Eapen S, Wu P, Prochaska JJ. Cardiovascular events associated with smoking cessation pharmacotherapies: A network meta-analysis. Circulation. 2014; 129(1): 28–41.
• Fiore MC, Jaen JR, Baker TB, et al. Treating tobacco use and dependence: clinical practice guideline. JAMA 2000; 283(24): 3244- 3254.
• Hernández-Pérez A, García-Gómez L, Robles-Hernández R, et al. Addiction to tobacco smoking and vaping. Rev Invest Clin 2023; 75(3): 158-168.
• Obert JL, McCann MJ, Marinelli-Casey P, et al. The matrix model of outpatient stimulant abuse treatment: history and description. J Psychoactive Drug, 2000; 32(2): 157-164.
• Aryan N, Banafshe HR, Farnia V, et al. The therapeutic effects of methylphenidate and matrix-methylphenidate on addiction severity, craving, relapse and mental health in the methamphetamine use disorder. Subst Abuse Treat Prev Policy. 2020;15(1): 72.
• Lechner WV, Sidhu NK, Cioe PA, Kahler CW. Effects of time-varying changes in tobacco and alcohol use on depressive symptoms following pharmaco-behavioral treatment for smoking and heavy drinking. Drug Alcohol Depend 2019; 194: 173-177.
• Weinberger AH, Pilver CE, Desai RA, et al. The relationship of major depressive disorder and gender to changes in smoking for current and former smokers: longitudinal evaluation in the US population. Addiction 2012; 107(10): 1847-1856.
• Grossman J, Donaldson S, Lisa B, Oliver. RH. 5 A’s Smoking Cessation with Recovering Women in Treatment, J Addict Nurs 2008;19(1): 1-8.
• Miller W. Rollnick S. Motivational interviewing. In Preparing people to change addictive behavior. New York: Guilford Press, 1991.
• Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev. 2017;3(3):CD001292.
• Garvey AJ, Kalman D, Hoskinson RAJr, et al. Front-loaded versus weekly counselling for treatment of tobacco addiction. Nicotine Tob Res 2012; 14(5): 578-585.
• Tomioka H, Sekiya R, Nishio C, Ishimoto G. Impact of smoking cessation therapy on health-related quality of life. BMJ Open Respir Res 2014; 1: e000047.
• Lee EJ. Long-term effects of smoking cessation on depressive symptoms, resilience, coping skills, and serotonin. Psychiat Q 2019; 91(2): 263-271.
• Rodríguez-Cano R, Lopez-Duran A, Del Rio EF et al. Smoking cessation and depressive symptoms at 1,3,6, and 12-months follow-up. J Affect Disord 2016; 191: 94-99.
• Becoña E, Martinez-Vispo C, Senra C, et al. Cognitive-behavioural treatment with behavioural activation for smokers with depressive symptomatology: study protocol of a randomized controlled trial. BMC Psychiatry 2017;17.
• Agarwal A, Das M, Jaiswal PL, Kashyap P. Behavioral therapy and pharmacotherapy: A case report on right approach for tobacco cessation. J Can Res Ther 2023;19(Suppl): S0.
• Secades-Villa R, Gonzalez-Roz A, Vallejo-Seco G, et al. Additive effectiveness of contingency management on cognitive behavioural treatment for smokers with depression: six-month abstinence and depression outcomes. Drug Alcohol Depend 2019; 204:107495.
• Matkin W, Ordóñez-Mena JM, Hartmann-Boyce J. Telephone counselling for smoking cessation. The Cochrane database of systematic reviews. 2019;5(5):CD002850.
• Cinciripini PM, Robinson JD, Karam-Hage M et al. Effects of varenicline and bupropion sustained-release use plus intensive smoking cessation counselling on prolonged abstinence from smoking and on depression, negative affect, and other symptoms of nicotine withdrawal. JAMA Psychiatry. 2013; 70(5): 522-533.
• Busch AM, Wagener TL, Gregor KL, et al. Utilizing reliable and clinically significant change criteria to assess for the development of depression during smoking cessation treatment: the importance of tracking idiographic change. Addict Behav 2011; 36(12): 1228-1232.
• Haokip HR, Kumar R, Rawat VS, Kumar Sarma S. Efficacy of standard nicotine replacement therapy (NRT) versus video-assisted nurse-led NRT on tobacco cessation: A randomized controlled pilot trial Clin Epidemiol Glob Health 2021; 9: 141-146
• Covey LS, Hu MC, Winhusen T, et al. Anxiety and depressed mood decline following smoking abstinence in adult smokers with attention deficit hyperactivity disorder. J Subst Abuse Treat 2015; 59:104-108.
• Dedert EA, Resick PA, Dennis PA et al. Pilot trial of a combined cognitive processing therapy and smoking cessation treatment. J Addict Med 2019; 13(4): 322-330.
• Avery N, Kenny AM, Kleppinger A, et al. Effects of varenicline, nicotine or placebo on depressive symptoms in postmenopausal smokers. Am J Addict 2014; 23(5): 459-65.
• Segan CJ, Borland R, Wilhelm KA, et al. Helping smokers with depression to quit smoking: collaborative care with Quitline. Med J Aust 2011; 195(3): 7-11.
• Berlin I, Chen H, Covey LS. Depressive mood, suicide ideation and anxiety in smokers who do and smokers who do not manage to stop smoking after a target quit day. Addiction 2010; 105(12): 2209-2216.
• Kahler CW, Spillane NS, Day A, et al. Positive psychotherapy for smoking cessation: treatment development, feasibility and preliminary results. J Posit Psychol 2014; 9(1): 19-29.
• Lenz B, Eichler A, Schwenke E, et al. Mindfulness-based Stress Reduction in Pregnancy: an App-Based Programme to Improve the Health of Mothers and Children (MINDFUL/PMI Study). Geburtshilfe Frauenheilkd 2018; 78(12): 1283-1291.
• Pine Abate H, Mcneill A, Muray R, et al. Survey of tobacco dependence treatment services in 121 countries. Addiction 2013; 108: 1476-1484.
• Sarna L, Bialous SA, Wewers ME, et al. Nurses, smoking and the workplace. Res Nurs Health 2005; 28(1) :79-90.
• JCS Joint Working Group. Guidelines for Smoking Cessation JCS 2010-Digest Version- Circ J 2012; 76:1024-1043.
• Kamisli S, Oz F. Evaluation of a smoking cessation psychoeducational program for nurses. J Addict Nurs 2011;22(3):117-123.
• Sağlık Bakanlığı, Tütün ve Madde Bağımlılığı ile mücadele, https://hsgm.saglik.gov.tr/tr/bagimliliklamucadele.html (Accessed 01.08.2024).
• Karakaş, S. Prof. Dr. Sirel Karakaş Psikoloji Sözlüğü: Bilgisayar programı ve veritabanı - www.psikolojisozlugu.com (sürüm: 5.2.0/2022) (Accessed 26.10.2024)
• Erdoğan MM, Kocataş S. The prevalence of smoking among soldiers of the gendarmerie in a provincial center and affecting factors: A cross-sectional study from Turkey. Arch Environ Occup Health 2023; 78(6): 347-356.
• Oflaz F, Yıldırım N. Psikiyatri Hemşireliği Sertifika Konuları. Ankara Nobel Tıp Kitabevleri, Ankara. 2020.
• TC Sağlık Bakanlığı Hemşirelik Yönetmeliği, https://www.mevzuat.gov.tr/mevzuatmetin/yonetmelik/7.5.13830ek.2%20ve%203.(Accessed 10.05.2024).
• Seng S, Otachi JK, Okoli CT. Reasons for tobacco use and perceived tobacco-related health risks in an inpatient psychiatric population. Issues Ment Health Nurs 2020; 41(2): 161-167.
• Oliveira RM, Santos JLF, Furegato ARF. Tobacco addiction in the psychiatric population and in the general population. Rev Lat Am Enfermagem 2017; 25 :e2945.
• Caponnetto P, Maglia M, Mangione M, et al. Smoking addiction in patients with schizophrenia spectrum disorders and its perception and intervention in healthcare personnel assigned to psycho-rehabilitation programs: a qualitative research. Healthcare 2022; 10(11): 2275-2285
• Wye P, Bowman J, Wiggers J, et al. Providing nicotine dependence treatment to psychiatric inpatients: the views of Australian nurse managers. J Psychiatr Ment Hlt 2010; 17(4): 319-327.
• Kutlu R, Demirbaş N. Üniversite personelinde tütün ve tütün ürünleri kullanım sıklığı ve tütün kontrol yasasına uyumları. Avrasya Sağlık Bilimleri Dergisi 2020; 3(2): 62-68.
• Martínez C, Castellano Y, Laroussy K, et al. Knowledge, attitudes, and training in tobacco dependence and cessation treatment among Nursing Students in Catalonia (ECTEC Study): cross-sectional study. Int J Ment Health Addict 2023; 21(2):1041-1056.
• Topcu M, Zorlu S. Sağlık çalışanlarının nargile içme profilleri, nargilenin sağlığa olan etkilerine yönelik algıları ve sağlıklı yaşam biçimi davranışları. Bağımlılık Dergisi 2021; 22(4): 432-446.
• Pipe A, Sorensen M, Reid R. Physician smoking status, attitudes toward smoking, and cessation advice to patients: an international survey. Patient Educ Couns 2009; 74(1): 118-123.
• Frank E, Carrera JS, Elon L, Hertzberg VS. Predictors of US medical students’ prevention counseling practices. Prev Med 2007; 44(1): 76-81.
• Cataldo JK. The role of advanced practice psychiatric nurses in treating tobacco use and dependence. Arch Psychiatr Nurs 2001;15(3):107-119.
• Smith LM, Boehm L, Strang LV, DeMarre C, Marcyjanik D. Targeted education for school staff on electronic nicotine delivery systems: A Nurse Led Intervention. J Sch Nurs 2024; 40(2): 223-230.